Advertisement
Advertisement

RNXT

RNXT logo

RenovoRx Inc

1.10
USD
-0.15
-12.00%
Dec 18, 15:59 UTC -5
Closed
...

RenovoRx Inc Profile

About

RenovoRx Inc. is a biopharmaceutical company. It developed a therapy platform targeting difficult-to-treat tumors. RenovoRx Inc. is headquartered in Silicon Valley, California.

Info & Links

CEO

Shaun R. Bagai

Headquarters

4546 El Camino Real, Suite B1
Los Altos, CA 94022, UNITED STATES

Auditor

Baker Tilly US, LLP

Share holders

120

Employees

8

RenovoRx Inc Statistics

Valuation Measures

Market Capitalization2

26.40M

Enterprise Value

16.84M

Enterprise Value/EBITDA(ttm)

-1.66

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.34

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-205.96%

Return on Invested Capital(ttm)

-14.04%

Return on Assets(ttm)

-110.01%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-10.12M

Net Income Available to Common(ttm)

-9.16M

Diluted EPS(ttm)

-0.57

Share Statistics

Beta (5Y Monthly)

1.11

52-Week Change

68.97%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

24.00M

Dividend Yield

0.00%

Float4

22.30M

% Held by Insiders

7.10%

% Held by Institutions

3.10%

Balance Sheet

Total Cash(mrq)

9.56M

Total Cash Per Share(mrq)

0.40

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.66%

Quick Ratio(mrq)

5.66%

Book Value Per Share(mrq)

0.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.27

Free Cash Flow(ytd)

-6.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement